/content/dam/www/people-profile-photos/r/blossom-suravi-raychaudhuri/provider-blossom-suravi-raychaudhuri-directory-1x.jpg
/content/dam/www/people-profile-photos/r/blossom-suravi-raychaudhuri/provider-blossom-suravi-raychaudhuri-directory-2x.jpg
Raychaudhuri
Blossom Suravi Raychaudhuri, MD

Blossom Suravi Raychaudhuri, MD

Hematology-Oncology

  • Physician, Fred Hutch
  • Assistant Professor, Clinical Research Division, Fred Hutch
  • Assistant Professor, Division of Hematology and Oncology, University of Washington School of Medicine
Request an Appointment

About

Dr. Blossom Raychaudhuri is a board-certified physician and researcher at Fred Hutch. She specializes in blood cancers and focuses on bringing the latest research directly into patient care. 

Background

Dr. Raychaudhuri is a hematologist-oncologist who treats patients with blood cancers. She cares for people with complex cases and works to ensure that advances in research are translated to the front line of care, where they can most directly benefit patients.

Her research focuses on the development of clinical trials for novel treatments and prognostic strategies for acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). She has experience designing and conducting both Phase 1 and Phase 2 clinical trials for patients with relapsed or refractory AML and MDS. 

Dr. Raychaudhuri previously served as chief fellow in the Fred Hutch/University of Washington Hematology Oncology Fellowship Program, reflecting her commitment to both research and education. She was a 2026 recipient of the American Society of Clinical Oncology Young Investigator Award for a clinical trial testing the immune-targeting drug axatilimab along with CLAG-M, a combination chemotherapy commonly used for relapsed or refractory AML (R/R AML).

Area of Clinical Practice
Malignant hematology

“What drew me to medicine are the relationships I form with patients and the difference we can make through research.”

— Dr. Raychaudhuri

What brought you to oncology?

The biggest driving factors that brought me to oncology were the relationships I had with patients with leukemia during my early training. I am also motivated by the desire to focus on the gaps that still exist in leukemia treatment and how research can contribute to addressing them. I credit a lot of this motivation to the mentorship I have had in my clinical research training.

What do you hope it’s like for a patient to work with you? 

I hope patients find me to be someone they can trust and who will be honest with them throughout the whole experience. My goal is to be a doctor they can rely on and who can determine a path forward.

Diseases Treated

Acute Myeloid Leukemia

Leukemia

Myelodysplastic Syndrome

Myeloproliferative Neoplasms

Diseases Researched

Acute Myeloid Leukemia

Myelodysplastic Syndrome

Languages

English

Education and Experience

Fellowship, Hematology and Medical Oncology, Fred Hutch/University of Washington, 2025

Residency, Internal Medicine, Stanford University Medical Center, 2022

MD, University of California, San Francisco, 2019

BS, Chemical Biology, University of California, Berkeley, 2014

Board Certifications

Hematology, 2025; Internal Medicine, 2019; American Board of Internal Medicine

Awards

ASCO Young Investigator Award, 2026

NIH Loan Repayment Program Awardee, National Institutes of Health, 2025

Clinical Trials

We make promising new treatments available to you through studies called clinical trials led by Fred Hutch physicians and researchers. Many of these trials at Fred Hutch have led to FDA-approved treatments and have improved standards of care globally. Together, you and your physician can decide if a study is right for you.

View Clinical Trials Led by Dr. Raychaudhuri

Publications

Many of our Fred Hutch physicians and researchers conduct ongoing research to improve standards of patient care. Their work is evaluated by other physicians and selected for publication to the United States National Library of Medicine, the largest medical library in the world. See scientific papers this Fred Hutch physician has written.

View Dr. Raychaudhuri's Publications

Your Care Team

At Fred Hutch, you receive care from a team of providers with extensive experience in your disease. Your team includes physicians, a patient care coordinator, a registered nurse, an advanced practice provider and others, based on your needs. You also have access to experts like registered dietitians, social workers, acupuncturists, psychiatrists and more who specialize in supporting people with cancer or blood disorders.

Meet Other Providers

Insurance

Fred Hutch accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.

More About Insurance

Stories

All news
ASCO Young Investigator Award winners showcase the breadth and depth of Fred Hutch research
ASCO Young Investigator Award winners showcase the breadth and depth of Fred Hutch research Hematology-oncology fellows and faculty receive $50,000 each toward early-career projects May 28, 2026